Hepatitis C virus infection in a first level rural hospital: Descriptive study in the decade 1991-1999;Infección por el virus de la hepatitis C en un hospital de primer nivel de ámbito rural: Estudio descriptivo en la década 1991-1999

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 3, 2003, Pages 142-146

  Rodríguez Vidigal, Francisco Félix ^a,b   Baz, Maria José ^a   Fernández, Francisco Javier ^a   Najarro, Francisco ^a  

^a Hospital Comarcal de Zafra   (Spain)

^b Hospital de Llerena   (Spain)

Author keywords

Epidemiology; Hepatitis C virus; Hepatocarcinoma; Human immunodeficiency virus

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; COMORBIDITY; ECHOGRAPHY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PROGNOSIS; RISK FACTOR; RURAL AREA; VIRUS TRANSMISSION;

EID: 0345268717     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0213-005x(03)72903-6     Document Type: Article

References (30)

1. Crespo J, Dueñas C, Sánchez-Antolín G, Fábrega E, Carte B, Pons-Romero F. Infección pr el virus de la hepatitis B y C en pacientes con carcinoma hepatocelular. Med Clin (Barc) 1996;106:241-5.
2. Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 2000;32 (Suppl 1):98-112.
3. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000;132: 296-305.
4. Tong MJ, El-Farra NS, Reijes AR, Co RL. Clinical outcomes after transfusion-assoaciated hepatitis C. N Engl J Med 1995;332:1463-6.
5. Poynard T, Bedossa P, Opolon P for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver tibrosis progression inpatients with chronic hepatitis C. Lancet 1997;349:825-32.
6. Soto B, Sánchez-Quijano A, Rodrigo L, Olmo JA, García-Bengoechea M, Hernandez Qhero J, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997;26:1-5.
7. Wiley TE, McCarcthy M, Breidi L, McCarthy M, Layden TJ. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998;28:805-9.
8. Soriano V, García-Samaniego J, Rodríguez-Rosado R, González J, Pedreira J. Hepatitis C and HIV infection: Biological, clinical, and therapeutic implications. J Hepatol 1999;31(Suppl 1):119-23.
9. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15:382-5.
10. Ferri C, La Civita L, Caracciolo F, Zigneno AI. Non-Hodgkin's lymphoma: possible role of hepatitis C virus. JAMA 1994;272:355-6.
11. Gumber S, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123:615-20.
12. Rivera J, García A, Millán J. Afectación extrahepática como primera manifestación de la infección por el virus de la hepatitis C. Med Clin (Barc) 1998;111:667-9.
13. Sacristán B, Gastañares MJ, Elena A, Sacristán M, Barcenilla J, García JC, et al. Infección por el virus de la hepatitis C. Estudio seroepidemiológico en población general de La Rioja. Med Clin (Barc) 1996;107:331-5.
14. Wasley A, Alter MJ. Epidemiology of hepatitis C: Geographic differencies and temporal trends. Semin Liver Dis 2000;20:1-16.
15. Touzet S, Kraemer L, Colin C, Pradat P, Lanoir D, Bailly F, et al. Epidemiology of hepatitis C virus infection in seven European Union countries: A critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research). Eur J Gastroenterol Hepatol 2000;12: 667-78.
16. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-9.
17. Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernandez JM, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294-7.
18. Bruguera M. Hepatitis C esporádica: importancia relativa de la transmisión vertical, sexual y parenteral inaparente del virus de la hepatitis C. Med Clin (Barc) 1998;111:658-9.
19. Galeazzi B, Tufano A, Barbierato E, Bortolotti F. Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver 1995;15:209-12.
20. Berenguer M, López-Labrador FJ. Coinfección por el virus de la hepatitis C y el virus de la inmunodeficiencia humana: implicaciones clínicas y biológicas. Med Clin (Barc) 1999;113:28-35.
21. Rodríguez-Vidigal FF, Roig V, Pérez-Lucena E, Ledesma V, Ramírez P, Aguilar FJ, et al. Hemorragia alveolar en el seno de una crioglobulinemia mixta asociada a infección por el virus de la hepatitis C. An Med Intern (Madrid) 1998;15:661-3.
22. Ferri C, Greco F, Longobardo G, Palla P, Moretti A, Marzo E, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9:95-6.
23. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
24. Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32 (Suppl 1):225-37.
25. Rodríguez-Vidigal FF, Aguilar J, Ramírez P, Najarro F, Mayoral L, Redondo L, et al. Hepatocellular carcinoma and hepatitis C infection in the South of Extremadura (Spain). Eur J Intern Med 1999;10:S129.
26. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000;14:703-9.
27. Hellerbrand C, Hartmann A, Richter G, Knoll A, Wiest R, Scholmerich J, et al. Hepatocellular carcinoma in southern Germany: Epidemiological and clinicopathological characteristics and risk factors. Dig Dis 2001;19:345-51.
28. Sikuler E, Shnaider A, Zuilberman D, Hilzanrat N, Shemer-Avni Y, Neumann L, et al. Hepatitis C virus infection and extrahepatic malignancies. J Clin Gastroenterol 1997;24:87-9.
29. De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Conrachiulo V, et al. Hepatitis C virus within a malignan lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;5:1887-92.
30. Ferri C, La Civita L, Zignego AL, Pasero G. Viruses and cancers: Posible role of hepatitis C virus. Enr J Clin Invest 1997;27:711-8.